Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should the treatment of osteoporosis be more selective?

Literature DB >> 12730748

Should the treatment of osteoporosis be more selective?

B E Christopher Nordin¹.

Abstract

Entities: Disease

Mesh：

Year: 2003 PMID： 12730748 DOI： 10.1007/s00198-002-1366-z

Source DB: PubMed Journal: Osteoporos Int ISSN： 0937-941X Impact factor: 4.507

Keyword Cloud
References

× No keyword cloud information.

29 in total

1. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density.

Authors: B Lawrence Riggs; L Joseph Melton
Journal: J Bone Miner Res Date: 2002-01 Impact factor: 6.741

2. Modification and validation of a single-isotope radiocalcium absorption test.

Authors: B E Nordin; H A Morris; J M Wishart; F Scopacasa; M Horowitz; A G Need; P M Clifton
Journal: J Nucl Med Date: 1998-01 Impact factor: 10.057

3. Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses.

Authors: B E Nordin; A G Need; H A Morris; M Horowitz
Journal: Osteoporos Int Date: 1999 Impact factor: 4.507

4. The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women.

Authors: N H Bjarnason; K Bjarnason; C Hassager; C Christiansen
Journal: Bone Date: 1997-02 Impact factor: 4.398

Review 5. Calcium and osteoporosis.

Authors: B E Nordin
Journal: Nutrition Date: 1997 Jul-Aug Impact factor: 4.008

6. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors: B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal: JAMA Date: 1999-08-18 Impact factor: 56.272

Should the treatment of osteoporosis be more selective?

1. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density.

2. Modification and validation of a single-isotope radiocalcium absorption test.

3. Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses.

4. The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women.

Review 5. Calcium and osteoporosis.

6. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

7. Calcium absorption in normal and osteoporotic postmenopausal women.

8. Relation of fractional 47Ca retention to season and rates of bone loss in healthy postmenopausal women.

9. An investigation of sources of variation in calcium absorption efficiency.

10. The effect of calcium supplementation on the circadian rhythm of bone resorption.